Red Blood Cell Disorders

Slides:



Advertisements
Similar presentations
HEMATOLOGY WHAT IT IS : Study & measurement of individual elements of Blood. WHAT IT’S COMPOSED OF. SHOW SLIDES FROM PERIPHERAL BLOOD TUTOR CD OR USE PLATE.
Advertisements

Anemia: Diagnosis and Clinical Considerations
Classification of anemia
Alterations of Erythrocyte Function
Anemia Dr. Meg-angela Christi M. Amores. What is Hematopoeisis? It is the process by which the formed elements of the blood are produced Erythropoeisis:
ANEMIA DEFINITION & CLASSIFICATION
MLAB Hematology Keri Brophy-Martinez
MLAB 1415: Hematology Keri Brophy-Martinez
MLAB 1415: Hematology Keri Brophy-Martinez Anemia Part Three.
NEOPLASTIC DISORDERS OF THE BONE MARROW
Anemia: Diagnosis and Clinical Considerations
Week 2: Hemolytic Anemia
GROUP CASE STUDY Dr. Nancy McQueen MICR Hematology Spring, 2011
CLASSIFICATION OF ANEMIAS
Week 1: Microcytosis Anemia classification Anemia classification Micro-Hypo anemia Micro-Hypo anemia CBC and histogram CBC and histogram IDA IDA Fe metabolism.
Dr.Leni Lismayanti, SpPK Dept of Clinical Pathology RSHS/FKUP Bandung
Chapter 14: The Cardiovascular System- Blood. Functions of the Blood 1)Transportation -Gases (O 2 and CO 2 ) -Nutrients -Heat and waste -Hormones 2)Regulation.
INTRODUCTION TO ANEMIA Definition. Age, Sex and other factors. Causes of Anemia. Clinical diagnosis. Classification of Anemia. Laboratory Tests in the.
Laboratory diagnosis of Anemia
Chapter 7 Disorders of Blood Cells Lecture 7 The Nature of Disease Pathology for the Health Professions Thomas H. McConnell.
MLAB 1415: Hematology Keri Brophy-Martinez
White blood cells Platelets Red blood cells Artery.
MLAB Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez Unit 23: CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)
MLAB 1415-Hematology Keri Brophy-Martinez Chapter 14: Introduction to Hemolytic Anemias.
Lecture 2 Red Blood Cells, Anemias & Polycythemias
MLAB 1415: Hematology Keri Brophy-Martinez Chapter 8: Anemia Part Two.
Erythrocytic Morphology and Associated Diseases(Size and Shape)
Red blood Cell Changes and Circulatory problems
IRON DEFICIENCY ANEMIA/ ANEMIA OF CHRONIC DISEASE
Nada Mohamed Ahmed , MD, MT (ASCP)i
Hemolytic anemias.
Objectives : When you complete this section ,you should be able to :
CLASSIFICATION OF ANEMIA
Anaemia Anemia is not a "disease" on its own rather it is the effect of another underlying reason which leads to anemia development. That.
Approach to Anemia Sadie T. Velásquez, M.D.. Objectives.
Anemia Presented by M.A. Kaeser, DC Fall 2009
Liver Function Tests (LFTs) Measurement of Serum Bilirubin (Total, direct &indirect) T.A. Bahiya Osrah.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives Intoduction Definition Classification Intravascular &extra vascular hemolysis Signs of hemolytic anemias.
Physiology of Red Blood Cells (RBCs) Erythrocytes
Anemia of chronic disease is a hypoproliferative ( بالتدريج) anemia associated with chronic infectious or inflammatory processes, tissue injury, or conditions.
Tabuk University Tabuk University Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 2 nd Year – Level 4 – AY
AN APPROACH TO THE ANEMIC PATIENT. Prevalence and causes of anemia world-wide Blood 2014;123:615 Us More common in women Iron deficiency most common cause.
MLAB Hematology Keri Brophy-Martinez
Classification of Anaemia
Acquired Hemolytic Anemias
1 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE Chapter 20. Erythrocytic disorders.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives chronic myeloid leukaemia (CML) Haematopoietic malignancies Polycythemia vera (PV) Idiopathic myelofibrosis.
Anemia of chronic disease = Anemia of chronic disorders (ACD) 1.
MLAB Hematology Keri Brophy-Martinez
MLAB 1415-Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
HEMATOLOGY/ HEMATOPOIESIS
MLAB 1415:Hematology Keri Brophy-Martinez
Introduction To Medical Technology
MLAB 1415: Hematology Keri Brophy-Martinez
Ch 11 Blood.
Anemia By: Dr Sunita Mittal.
MLAB 1415-Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
ANEMIA MAGDI AWAD SASI MAGDI AWAD SASI. NORMAL PERIPHERAL SMEAR.
HEMOLYTIC ANEMIA Dr Ramadas Nayak
MLAB 1415-Hematology Keri Brophy-Martinez
Anemia of chronic disease =Anemia of chronic disorders (ACD)
MLAB 1415:Hematology Keri Brophy-Martinez
Anemia case study Made by :Alaa duhair , Alaa alhoubi ,Shimaa Alshakhe. Under the supervision of : MS. Ibtisam Alaswad .
Male patient of 52 years old with a two-year history of fatigue and pruritus of his legs , headache . And visual disturbances . He smoked one pack of.
Approach to Haemolysis
Presentation transcript:

Red Blood Cell Disorders DR.Leni Lismayanti, SpPK-K Dept of Clinical Pathology RSHS/FKUP Bandung

Reference book: Denise M Harmening. Clinical Hematology and Fundamental of Hemostasis. 5th edition. Philadelphia: FA Davis Co, 2009.

RBC Structure & Function Areas of RBC metabolism important in normal RBC survival and function: RBC membrane Hb structure & function RBC metabolic pathway

RBC Membrane RBC membran proteins: Deformability Permeability RBC membran lipids: Phospholipd Glycolipid cholesterol

RBC membrane

Abnormality That Can Lead to a Change in RBC Morphology Cholesterol accumulation in the RBC membrane (liver disease) Target cells Abetalipoproteinemia with cholesterol accumulation Acanthocytes LCAT deficiency with cholesterol accumulation Hemolysis with RBC fragmentation Decreased phosphorylated spectrin or altered spectrin Bite cells and spherocytes

Hb Structure & Function Hb function: delivery and release of oxygen to the tissue and facilitation of CO2 excretion. Hb synhesis depends on 3 prs: Adequate Iron delivery & supply Adequate synthesis of protophorphyrin Adequate globin synthesis

RBC Metabolic Pathway ATP needs for: Hb function Membrane integrity & deformability RBC volume Adequate amounts of reduced pyridine nucleotides Protection of metabolic enzymes

RBC Senescence & Hemolysis RBC traveles 200-300 miles during 120 day life span  undergo the process of senescence (aging)  metabolic & physical changes. 1% RBC taken out (removed) from circulation by RES/MPS  process: Extravascular hemolysis (90%) Intravascular hemolysis (5-10%)

Extravascular Hemolysis

Any questions?

RBC Disorders: RBC disorders  morphologic changes Numbers: Decreased (Anemia) Increased (Polycythemia) Structure and function: Hemoglobin RBC membrane Abnormal erythropoiesis  nutritional RBC disorders  morphologic changes

Anemia Inability of the circulating blood pool to supply the tissue with adequate oxygen for proper metabolic function. Clinically d/ based on: HT, SS, PE, Lab. Caused by or associated with underlying disease. Usually associated with decrease Hb & Hct (Lab: + RBC count). Consideration by age, sex and other fact

Classification of Anemia Based on Hb level: Moderate (7-10), severe (<7). BM dynamic: Hypoproliferative Accelerated destruction combination Clinically (caused): RBC indices (normochromic normocytic)

Categories of anemia by causes Blood loss Accelerated destruction Nutritional deficiency BM replacement Infection Toxicity Hematopoietic SC arrest/damage Hereditary/acquired defect idiopathic

Significance of Anemia and Compensatory Mechanism N: 1% of RBC loss daily  BM produce (measured by reticulocyte count  0.5-2.0%). Replacement RBC requires: Adequate functioning SC in BM Normal RBC maturation process Ability to release mature RBC from BM

Proper HB & RBC production requires: Variety of nutritional factors Normal pathway of Bh synthesis In severe anemias  symptoms of functional impairment of several organs (+). Compensatory mechanism  increase 2,3-DPG levels

2,3-DPG Physiologic regulator of: Normal Hb oxygen-carrying capacity Tissue oxygen delivery 2,3-DPG (+)  Hb more readily released oxygen to tissues  depend on: pH & Oxygen level of arterial blood. N individual responds to anemia  elevated EPO  Recombinant EPO  Th/ certain anemia.

Lab Tests in Diagnosis of Anemia Hb Hct (RBC Count) RBC indices Peripheral Blood Smear Reticulocyte Count BM smear/biopsy Treatment of anemia: depends on etiology

Polycythemia Polycythemia Vera (Myeloproliferative disorders). Secondary Hypoxic Polycythemia (Secondary Erythrocytosis). Relative Erythrocytosis.

Manifestations PV SE RE CLINICAL FEATURES Cyanosis Absent Present Maybe present Heart/lung disease Splenomegaly Present in 75% Hepatomegaly Present in 35% LAB FEATURES RBC mass Increased Normal EPO Decreased (rarely N) Increased (rarely N) Arterial O2 saturation Decreased WBC count Increased in 80% Platelet count Increased in 50% NRBCs poikilocytes Often present LAP Increased in 70% BM Hypercell; eryth & myelop ↑; Erythropoiesis ↑ Megakaryocytes ↑; fibrosis Serum vit B12 Increased in 75% Culture studies Autonomous, ery proliferation EPO dep.col.form Not applicable

Any questions?

RBC Morphology

Thank You Very Much for Your Attention